Expansion Opportunity The sale of Clearwater Paper's tissue business to Sofidel for $1.06B in 2024 indicates a strategic shift and potential appetite for divestitures or partnerships in the tissue and consumer tissue value chain, suggesting opportunities to engage on remaining paper and board products or new distribution arrangements.

Financial Signals Revenue in the stated range of 10 to 25 million coupled with recent headcount reductions and asset investments signals a company in transition, creating openings for cost optimization solutions, automation upgrades, or multi-year supplier contracts to improve efficiency.

Automation & Tech Active use of automation and industrial tech such as Rockwell, Honeywell, Fortinet, and UNIX shell indicates a buyer profile receptive to integrated Factory Automation, cybersecurity hardening, and data analytics offerings for plant operations and safety enhancements.

Strategic Partnerships Participation in multiple materials and agricultural conferences and a focus on industrial assets position Clearwater Paper as a potential partner for joint ventures, co-marketing, or supplier programs within North American tissue and packaging ecosystems.

Geographic Scope A mix of North American manufacturing assets (e.g., Shelby, NC) with a UK base suggests opportunities for cross-border supply chain services, logistics optimization, and regional compliance solutions to support any remaining or nearby operations.